Journal articleClin Cancer Res2020

A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.

DOI 10.1158/1078-0432.ccr-20-1301 ↗ OpenAlex, retrieved 5 November 2026

Journal: Clin Cancer Res
Published: 15 July 2020
Citations: 37
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Grants 3

Gastrointestinal Cancer P30CA056036 ↗
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600 ↗
Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens U01CA224012 ↗